{"id":"https://openalex.org/W4403554252","doi":"https://doi.org/10.1016/j.htct.2024.09.1015","title":"CARACTERIZA\u00c7\u00c3O DO PERFIL FARMACOL\u00d3GICO E TOXICOL\u00d3GICO DE NANOPART\u00cdCULAS DE RIVAROXABANA VISANDO O TRATAMENTO DE DIST\u00daRBIOS TROMB\u00d3TICOS","display_name":"CARACTERIZA\u00c7\u00c3O DO PERFIL FARMACOL\u00d3GICO E TOXICOL\u00d3GICO DE NANOPART\u00cdCULAS DE RIVAROXABANA VISANDO O TRATAMENTO DE DIST\u00daRBIOS TROMB\u00d3TICOS","alternate_titles":[],"publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403554252","doi":"https://doi.org/10.1016/j.htct.2024.09.1015"},"language":"es","primary_location":{"id":"doi:10.1016/j.htct.2024.09.1015","doi":"https://doi.org/10.1016/j.htct.2024.09.1015","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1015","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4403554252"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2024.09.1015","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085609922","display_name":"A. H. Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"AASC Oliveira","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":null,"display_name":"PS Rodrigues","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"PS Rodrigues","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":null,"display_name":"PS Furtado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"PS Furtado","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068151285","display_name":"Alice Simon","orcid":"https://orcid.org/0000-0002-4673-6182","observed_orcids":["https://orcid.org/0000-0002-4673-6182"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"A Simon","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":null,"display_name":"FAD Carmo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"FAD Carmo","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102520609","display_name":"LM Cabral","orcid":"https://orcid.org/0000-0003-3435-3237","observed_orcids":["https://orcid.org/0000-0003-3435-3237"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"LM Cabral","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064204540","display_name":"P.C Sathler","orcid":"https://orcid.org/0000-0003-1203-3179","observed_orcids":["https://orcid.org/0000-0003-1203-3179"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"PC Sathler","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil","institution_ids":["https://openalex.org/I122140584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I122140584"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":null,"first_page":"S605","last_page":"S605"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-nanoparticles","display_name":"drug nanoparticles","score":0.5709999799728394},{"id":"https://openalex.org/keywords/plga","display_name":"PLGA","score":0.7200000286102295},{"id":"https://openalex.org/keywords/sodium-dodecyl-sulfate","display_name":"sodium dodecyl sulfate","score":0.9629999995231628},{"id":"https://openalex.org/keywords/anticoagulants","display_name":"anticoagulants","score":0.593999981880188},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.8579999804496765},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.6470000147819519},{"id":"https://openalex.org/keywords/nanoprecipitation","display_name":"nanoprecipitation","score":0.8619999885559082},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antithrombotic-activity","display_name":"antithrombotic activity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.3799999952316284},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.5339999794960022},{"id":"https://openalex.org/keywords/nanoparticle-characterization","display_name":"nanoparticle characterization","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9133893251419067},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3299497961997986},{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.32841354608535767},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2024.09.1015","doi":"https://doi.org/10.1016/j.htct.2024.09.1015","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1015","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:d547065daa9146aebf7e0ba19fd0fa05","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/d547065daa9146aebf7e0ba19fd0fa05","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S605- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2024.09.1015","doi":"https://doi.org/10.1016/j.htct.2024.09.1015","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1015","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3107732508","https://openalex.org/W4385394643","https://openalex.org/W7223092865","https://openalex.org/W2753767629","https://openalex.org/W6976907003","https://openalex.org/W3194041471","https://openalex.org/W2152925634","https://openalex.org/W951969555","https://openalex.org/W2583096364","https://openalex.org/W4292511280"],"abstract_inverted_index":{"As":[0,260,352,394],"doen\u00e7as":[1],"cardiovasculares":[2],"representam":[3],"uma":[4,92,408],"das":[5,113,136,163,369],"principais":[6],"causas":[7],"de":[8,32,51,72,75,79,90,119,122,133,142,144,156,170,176,183,197,217,225,252,256,275,284,300,357,359,371,402,420,430,460],"mortalidade":[9],"em":[10,245,391],"todo":[11],"mundo":[12],"e":[13,65,70,82,100,130,147,151,173,219,231,248,291,311,326,339,363,405,413,423,443,455],"dentre":[14],"elas,":[15],"\u00e9":[16,27,63,436],"poss\u00edvel":[17,437],"destacar":[18],"o":[19,59,67,111,117,131,204,211,340,388,458],"tromboembolismo":[20],"venoso.":[21],"O":[22,127],"tratamento":[23,459],"deste":[24],"quadro":[25],"patol\u00f3gico":[26],"baseado":[28],"principalmente":[29,47],"na":[30,55,418],"utiliza\u00e7\u00e3o":[31],"medicamentos":[33],"anticoagulantes,":[34],"como":[35,281],"a":[36,88,148,174,223,336,384],"Rivaroxabana":[37],"(RXB).":[38],"Tal":[39],"f\u00e1rmaco":[40],"pode":[41],"causar":[42],"efeitos":[43],"adversos":[44],"aos":[45],"pacientes,":[46],"hemorragias":[48],"graves,":[49],"apesar":[50],"sua":[52],"ampla":[53],"aplica\u00e7\u00e3o":[54],"cl\u00ednica.":[56],"Nessa":[57],"perspectiva,":[58],"objetivo":[60],"desse":[61,108],"trabalho":[62],"caracterizar":[64],"avaliar":[66,236],"perfil":[68,205,212,397],"farmacol\u00f3gico":[69],"toxicol\u00f3gico":[71,206,398],"Nanopart\u00edculas":[73],"(NPs)":[74],"poli(\u00e1cido":[76],"l\u00e1tico-co-glic\u00f3lico)/Lauril":[77],"Sulfato":[78],"S\u00f3dio":[80],"(LSS)":[81],"Brometo":[83],"Didodecildimetilam\u00f4nio":[84],"(DMAB)":[85],"contendo":[86,267,305],"rivaroxabana,":[87,268],"fim":[89],"estabelecer":[91],"nova":[93],"proposta":[94],"terap\u00eautica,":[95],"que":[96,106,410,439],"apresente":[97],"menor":[98],"risco":[99,401],"maior":[101],"efic\u00e1cia":[102],"para":[103,235,345,349,457],"os":[104,239],"pacientes":[105],"necessitam":[107],"tratamento.":[109],"Para":[110,202],"desenvolvimento":[112],"NPs,":[114],"foi":[115,165,192,221,343,373],"utilizado":[116],"m\u00e9todo":[118,274,341],"nanoprecipita\u00e7\u00e3o,":[120,276],"adaptado":[121],"Barichello":[123],"et.":[124],"al,":[125],"1999.":[126],"di\u00e2metro":[128,282],"m\u00e9dio":[129,283],"\u00cdndice":[132],"Polidispersividade":[134],"(IPD)":[135],"nanopart\u00edculas":[137,164,441],"foram":[138,153,209,243,269],"avaliados":[139,210],"pela":[140],"t\u00e9cnica":[141],"espalhamento":[143],"luz":[145],"din\u00e2mico":[146],"carga":[149,301,312,327],"superficial":[150],"estabilidade":[152],"analisadas":[154],"atrav\u00e9s":[155,194,214],"medida":[157],"do":[158,215,347,396],"potencial":[159,308,324],"zeta.":[160],"A":[161,187,331,366],"morfologia":[162,337],"determinada":[166],"por":[167,178,375],"Microscopia":[168],"Eletr\u00f4nica":[169],"Transmiss\u00e3o":[171],"(MET)":[172],"efici\u00eancia":[175,358],"encapsulamento":[177,360],"meio":[179],"da":[180,195,333],"Cromatografia":[181],"L\u00edquida":[182],"Alta":[184],"Efici\u00eancia":[185],"(CLAE).":[186],"atividade":[188,367],"antitromb\u00f3tica":[189,368],"in":[190,200,207,241,381,433],"vivo":[191,242],"analisada":[193],"indu\u00e7\u00e3o":[196],"trombose":[198],"venosa":[199],"vivo.":[201,434],"analisar":[203],"vivo,":[208,382],"hemorr\u00e1gico":[213],"tempo":[216],"sangramento":[218],"tamb\u00e9m":[220],"realizada":[222],"quantifica\u00e7\u00e3o":[224,346],"enzimas":[226,431],"hep\u00e1ticas":[227,432],"Gama-Glutamil":[228],"Transferase":[229],"(GGT)":[230],"Fosfatase":[232],"Alcalina":[233],"(ALP)":[234],"hepatotoxicidade.":[237],"Todos":[238],"ensaios":[240],"realizados":[244],"ratos":[246],"Wistar":[247],"amparados":[249],"pelo":[250,273],"comit\u00ea":[251],"\u00e9tica":[253],"no":[254,445],"uso":[255],"animais":[257],"(CEUA":[258],"021/19).":[259],"NPs":[261,304,318,353],"estabilizadas":[262],"com":[263,271,320],"LSS":[264,306],"ou":[265],"DMAB":[266],"preparadas":[270],"sucesso":[272],"apresentaram":[277,307,354],"propriedades":[278],"f\u00edsico-qu\u00edmicas":[279],"adequadas,":[280],"(NPs-LSS-RXB":[285,293,361],"213,2\u00b12,46":[286],"nm),":[287],"(NPs-DMAB-RXB":[288,296,364],"275,8\u00b18,82":[289],"nm)":[290],"IPD":[292,294],"0,15\u00b10,01),":[295],"0,31\u00b10,04).":[297],"Nas":[298],"an\u00e1lises":[299,395],"superficial,":[302],"as":[303,317,411,440],"zeta":[309,325],"alto":[310,323],"ani\u00f4nica":[313],"(-69,12\u00b14,64":[314],"mV)":[315],"enquanto":[316,383],"desenvolvidas":[319,442],"DMAB,":[321],"mostraram":[322],"cati\u00f4nica":[328],"(+61,91\u00b14,52":[329],"mV).":[330],"partir":[332],"MET,":[334],"determinou-se":[335],"esf\u00e9rica":[338],"cromatogr\u00e1fico":[342],"adequado":[344],"rivaroxabana":[348],"ambas":[350],"NPs.":[351],"altos":[355],"percentuais":[356],"91,72\u00b12,35%)":[362],"95,68\u00b11,22%).":[365],"NPS":[370],"RXB":[372,385],"mantida":[374],"24":[376,392],"horas":[377],"ap\u00f3s":[378],"administra\u00e7\u00e3o":[379],"oral":[380],"n\u00e3o":[386,415,424],"manteve":[387],"efeito":[389],"antitromb\u00f3tico":[390],"horas.":[393],"demonstraram":[399],"baixo":[400],"eventos":[403],"hemorr\u00e1gicos":[404],"toxicidade":[406],"hep\u00e1tica":[407],"vez":[409],"NPs-LSS-RXB":[412],"NPs-LSS-DMAB":[414],"promoveram":[416],"altera\u00e7\u00f5es":[417,426],"quantidade":[419],"hemoglobina":[421],"liberada":[422],"induziram":[425],"significativas":[427],"nos":[428],"n\u00edveis":[429],"Assim,":[435],"considerar":[438],"caracterizadas":[444],"presente":[446],"trabalho,":[447],"podem":[448],"ser":[449],"alternativas":[450],"terap\u00eauticas":[451],"promissoras":[452],"mais":[453],"eficientes":[454],"seguras":[456],"dist\u00farbios":[461],"tromb\u00f3ticos":[462],"venosos.":[463]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4403554252","counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-10-19T00:00:00"}
